The U.S. Food and Drug Administration authorized at-home sample collection for LabCorp’s COVID-19 diagnostic kit, allowing patients to send in their nasal swab samples to the company’s labs for diagnosis.

Nasal Swab, COVID

Origin, a 3D printing specialist for medical devices, completed clinical trials and validation of the company’s 3D-printed nasopharyngeal swabs for use in COVID-19 test kits.